Clinical Report: Machine Learning for Cardiovascular Risk in Chronic Lung Disorders

Overview

This study developed machine learning-based models to predict cardiovascular disease (CVD) risk in patients with chronic lung disorders (CLD) using data from CHARLS and ELSA. The Extreme Gradient Boosting (XGBoost) model was identified as the optimal approach, demonstrating improved accuracy over traditional risk assessment tools.

Background

Chronic lung diseases (CLD) significantly increase the risk of cardiovascular disease (CVD), which is a leading cause of morbidity and mortality in this population. Current CVD risk assessment tools often fail to account for the unique characteristics of CLD patients, necessitating the development of tailored predictive models. Machine learning offers a promising avenue for enhancing risk stratification and clinical decision-making in this high-risk group.

Data Highlights

No numerical data available in the source material.

Key Findings

• Chronic lung diseases are associated with a significantly elevated risk of cardiovascular disease.
• Traditional CVD risk assessment tools do not adequately address the complexities of patients with CLD.
• Machine learning models, particularly XGBoost, outperform traditional statistical methods in predicting CVD risk.
• Integration of multidimensional variables improves the accuracy of CVD risk predictions in CLD patients.
• External validation using data from ELSA enhances the robustness of the developed models.

Clinical Implications

Healthcare professionals should consider utilizing machine learning-based models for more accurate CVD risk assessment in patients with chronic lung disorders. Early identification of high-risk individuals can facilitate timely interventions and improve long-term outcomes.

Conclusion

The study underscores the potential of machine learning in refining cardiovascular risk prediction for patients with chronic lung disorders, highlighting the need for tailored approaches in clinical practice.

Related Resources & Content

1. BMC Psychiatry, 2025 -- Creation of a machine learning tool for identifying depression risk in elderly individuals with asthma
2. Frontiers in Cardiovascular Medicine, 2026 -- Evaluation of coronary heart disease risk prediction based on simple physical examination parameters by machine learning model: a retrospective cohort model development and validation study
3. DIGITAL HEALTH, 2026 -- Development of a machine learning-based depression risk prediction model for middle-aged and elderly Chinese heart disease patients: Evidence from CHARLS data
4. 2025 GOLD Report on COPD Addresses Cardiovascular Risk in New Section: MeiLan Han, MD, MS, Highlights Rationale | Patient Care Online
5. The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies - PMC
6. Frontiers in Endocrinology — Development and external validation of an interpretable machine learning model for diagnosing coronary heart disease in patients with type 2 diabetes and MASLD
7. New PREVENT Equations for CVD Risk Assessment: Key Takeaways - American College of Cardiology
8. 2025 GOLD Report on COPD Addresses Cardiovascular Risk in New Section: MeiLan Han, MD, MS, Highlights Rationale | Patient Care Online
9. The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies - PMC
10. Development and validation of a new algorithm for improved cardiovascular risk prediction - PMC